{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T04:18:55Z","timestamp":1792037935800,"version":"4.4.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2005,5,12]],"date-time":"2005-05-12T00:00:00Z","timestamp":1115856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2005,5,12]],"date-time":"2005-05-12T00:00:00Z","timestamp":1115856000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2005,10]]},"DOI":"10.1007\/s00262-005-0667-4","type":"journal-article","created":{"date-parts":[[2005,5,11]],"date-time":"2005-05-11T08:44:27Z","timestamp":1115801067000},"page":"999-1009","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Complete protection against melanoma in absence of autoimmune depigmentation after rejection of melanoma cells expressing \u03b1(1,3)galactosyl epitopes"],"prefix":"10.1007","volume":"54","author":[{"given":"Gabriela R.","family":"Rossi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Unfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Seregina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles J.","family":"Link","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2005,5,12]]},"reference":[{"key":"667_CR1","doi-asserted-by":"crossref","first-page":"6460","DOI":"10.4049\/jimmunol.172.10.6460","volume":"172","author":"BC Baumann","year":"2004","unstructured":"Baumann BC, Forte P, Hawley RJ, Rieben R, Schneider MK, Seebach JD (2004) Lack of galactose-alpha-1,3-galactose expression on porcine endothelial cells prevents complement-induced lysis but not direct xenogeneic NK cytotoxicity. J Immunol 172:6460\u20136467","journal-title":"J Immunol"},{"key":"667_CR2","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s00262-003-0488-2","volume":"53","author":"Z Cui","year":"2004","unstructured":"Cui Z, Willingham MC (2004) The effect of aging on cellular immunity against cancer in SR\/CR mice. Cancer Immunol Immunother 53:473\u2013478","journal-title":"Cancer Immunol Immunother"},{"key":"667_CR3","doi-asserted-by":"publisher","first-page":"6682","DOI":"10.1073\/pnas.1031601100","volume":"100","author":"Z Cui","year":"2003","unstructured":"Cui Z, Willingham MC et al (2003) Spontaneous regression of advanced cancer: identification of a unique genetically determined, age-dependent trait in mice. Proc Natl Acad Sci USA 100:6682\u20136687","journal-title":"Proc Natl Acad Sci USA"},{"key":"667_CR4","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1189\/jlb.0304120","volume":"76","author":"SE Finkelstein","year":"2004","unstructured":"Finkelstein SE, Heimann DM et al (2004) Bedside to bench and back again: how animal models are guiding the development of new immunotherapies for cancer. J Leukoc Biol 76:333\u2013337","journal-title":"J Leukoc Biol"},{"issue":"11","key":"667_CR5","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s00262-004-0524-x","volume":"53","author":"U Galili","year":"2004","unstructured":"Galili U (2004) Autologous tumor vaccines processed to express alpha-gal epitopes: a practical approach to immunotherapy in cancer. Cancer Immunol Immunother 53(11):935\u2013945","journal-title":"Cancer Immunol Immunother"},{"key":"667_CR6","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1182\/blood.V82.8.2485.2485","volume":"82","author":"U Galili","year":"1993","unstructured":"Galili U, Anaraki F, Thall A, Hill-Black C, Radic M (1993) One percent of human circulating B lymphocytes are capable of producing the natural anti-Gal antibody. Blood 82:2485\u20132493","journal-title":"Blood"},{"key":"667_CR7","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0167-5699(97)80024-2","volume":"18","author":"U Galili","year":"1997","unstructured":"Galili U, LaTemple DC (1997) Natural anti-Gal antibody as a universal augmenter of autologous tumor vaccine immunogenicity. Immunol Today 18:281\u2013285","journal-title":"Immunol Today"},{"key":"667_CR8","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1128\/iai.56.7.1730-1737.1988","volume":"56","author":"U Galili","year":"1988","unstructured":"Galili U, Mandrell RE, Hamadeh RM, Shohet SB, Griffiss JM (1988) Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora. Infect Immun 56:1730\u20131737","journal-title":"Infect Immun"},{"key":"667_CR9","doi-asserted-by":"crossref","first-page":"17755","DOI":"10.1016\/S0021-9258(19)77900-9","volume":"263","author":"U Galili","year":"1988","unstructured":"Galili U, Shohet SB, Kobrin E, Stults CL, Macher BA (1988) Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. J Biol Chem 263:17755\u201317762","journal-title":"J Biol Chem"},{"key":"667_CR10","first-page":"4168","volume":"55","author":"E Gorelik","year":"1995","unstructured":"Gorelik E, Duty L, Anaraki F, Galili U (1995) Alterations of cell surface carbohydrates and inhibition of metastatic property of murine melanomas by alpha 1,3 galactosyltransferase gene transfection. Cancer Res 55:4168\u20134173","journal-title":"Cancer Res"},{"key":"667_CR11","first-page":"6944","volume":"62","author":"JW Greiner","year":"2002","unstructured":"Greiner JW, Zeytin H, Anver MR, Schlom J (2002) Vaccine-based therapy directed against carcinoembryonic antigen demonstrates antitumor activity on spontaneous intestinal tumors in the absence of autoimmunity. Cancer Res 62:6944\u20136951","journal-title":"Cancer Res"},{"key":"667_CR12","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1172\/JCI200419418","volume":"113","author":"DA Gross","year":"2004","unstructured":"Gross DA, Graff-Dubois S et al (2004) High vaccination efficiency of low-affinity epitopes in antitumor immunotherapy. J Clin Invest 113:425\u2013433","journal-title":"J Clin Invest"},{"key":"667_CR13","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1172\/JCI115706","volume":"89","author":"RM Hamadeh","year":"1992","unstructured":"Hamadeh RM, Jarvis GA, Galili U, Mandrell RE, Zhou P, Griffiss JM (1992) Human natural anti-Gal IgG regulates alternative complement pathway activation on bacterial surfaces. J Clin Invest 89:1223\u20131235","journal-title":"J Clin Invest"},{"key":"667_CR14","first-page":"1837","volume":"9","author":"JW Hodge","year":"2003","unstructured":"Hodge JW, Grosenbach DW, Aarts WM, Poole DJ, Schlom J (2003) Vaccine therapy of established tumors in the absence of autoimmunity. Clin Cancer Res 9:1837\u20131849","journal-title":"Clin Cancer Res"},{"key":"667_CR15","unstructured":"Induction and measurement of cytotoxic t lymphocyte activity (2001) Current protocols in immunology Chapter 3. In: Coico R (ed) Vitro Assays for Mouse Lymphocyte Function. John Wiley& Sons, New York"},{"key":"667_CR16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0925-4439(99)00056-3","volume":"1455","author":"DH Joziasse","year":"1999","unstructured":"Joziasse DH, Oriol R (1999) Xenotransplantation: the importance of the Galalpha1,3Gal epitope in hyperacute vascular rejection. Biochim Biophys Acta 1455:403\u2013418","journal-title":"Biochim Biophys Acta"},{"key":"667_CR17","doi-asserted-by":"crossref","first-page":"5406","DOI":"10.4049\/jimmunol.171.10.5406","volume":"171","author":"T Kawahara","year":"2003","unstructured":"Kawahara T, Ohdan H, Zhao G, Yang YG, Sykes M (2003) Peritoneal cavity B cells are precursors of splenic IgM natural antibody-producing cells. J Immunol 171:5406\u20135414","journal-title":"J Immunol"},{"key":"667_CR18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/glycob\/3.5.447","volume":"3","author":"M Kim","year":"1993","unstructured":"Kim M, Rao MV, Tweardy DJ, Prakash M, Galili U, Gorelik E (1993) Lectin-induced apoptosis of tumour cells. Glycobiology 3:447\u2013453","journal-title":"Glycobiology"},{"key":"667_CR19","doi-asserted-by":"crossref","first-page":"7055","DOI":"10.1016\/S0021-9258(19)39258-0","volume":"265","author":"RD Larsen","year":"1990","unstructured":"Larsen RD, Rivera-Marrero CA, Ernst LK, Cummings RD, Lowe JB (1990) Frameshift and nonsense mutations in a human genomic sequence homologous to a murine UDP-Gal:beta-D-Gal(1,4)-D-GlcNAc alpha(1,3)- galactosyltransferase cDNA. J Biol Chem 265:7055\u20137061","journal-title":"J Biol Chem"},{"key":"667_CR20","first-page":"3417","volume":"59","author":"DC LaTemple","year":"1999","unstructured":"LaTemple DC, Abrams JT, Zhang SY, Galili U (1999) Increased immunogenicity of tumor vaccines complexed with anti-Gal: studies in knockout mice for alpha1,3galactosyltransferase. Cancer Res 59:3417\u20133423","journal-title":"Cancer Res"},{"key":"667_CR21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1399-3089.1998.tb00027.x","volume":"5","author":"DC LaTemple","year":"1998","unstructured":"LaTemple DC, Galili U (1998) Adult and neonatal anti-Gal response in knock-out mice for alpha1,3galactosyltransferase. Xenotransplantation 5:191\u2013196","journal-title":"Xenotransplantation"},{"key":"667_CR22","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/nm813","volume":"9","author":"WW Leitner","year":"2003","unstructured":"Leitner WW, Hwang LN, deVeer MJ, Zhou A, Silverman RH, Williams BR, Dubensky TW, Ying H, Restifo NP (2003) Alphavirus-based DNA vaccine breaks immunological tolerance by activating innate antiviral pathways. Nat Med 9:33\u201339","journal-title":"Nat Med"},{"key":"667_CR23","first-page":"2301","volume":"18","author":"CJ Link Jr","year":"1998","unstructured":"Link CJ Jr, Seregina T, Atchison R, Hall A, Muldoon R, Levy JP (1998) Eliciting hyperacute xenograft response to treat human cancer: alpha(1,3) galactosyltransferase gene therapy. Anticancer Res 18:2301\u20132308","journal-title":"Anticancer Res"},{"key":"667_CR24","doi-asserted-by":"publisher","first-page":"2982","DOI":"10.1073\/pnas.96.6.2982","volume":"96","author":"WW Overwijk","year":"1999","unstructured":"Overwijk WW, Lee DS et al (1999) Vaccination with a recombinant vaccinia virus encoding a \u201cself\u201d antigen induces autoimmune vitiligo and tumor cell destruction in mice: requirement for CD4(+) T lymphocytes. Proc Natl Acad Sci USA 96:2982\u20132987","journal-title":"Proc Natl Acad Sci USA"},{"key":"667_CR25","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1084\/jem.20030590","volume":"198","author":"WW Overwijk","year":"2003","unstructured":"Overwijk WW, Theoret MR et al (2003) Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells. J Exp Med 198:569\u2013580","journal-title":"J Exp Med"},{"key":"667_CR26","doi-asserted-by":"publisher","first-page":"8372","DOI":"10.1073\/pnas.1533209100","volume":"100","author":"GQ Phan","year":"2003","unstructured":"Phan GQ, Yang JC et al (2003) Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma. Proc Natl Acad Sci USA 100:8372\u20138377","journal-title":"Proc Natl Acad Sci USA"},{"key":"667_CR27","doi-asserted-by":"publisher","first-page":"6215","DOI":"10.1128\/IAI.70.11.6215-6222.2002","volume":"70","author":"KJ Posekany","year":"2002","unstructured":"Posekany KJ, Pittman HK, Bradfield JF, Haisch CE, Verbanac KM (2002) Induction of cytolytic anti-Gal antibodies in alpha-1,3-galactosyltransferase gene knockout mice by oral inoculation with Escherichia coli O86:B7 bacteria. Infect Immun 70:6215\u20136222","journal-title":"Infect Immun"},{"key":"667_CR28","first-page":"605","volume":"24","author":"KJ Posekany","year":"2004","unstructured":"Posekany KJ, Pittman HK, Swanson MS, Haisch CE, Verbanac KM (2004) Suppression of Lewis lung tumor development in alpha 1,3 galactosyltransferase knock-out mice. Anticancer Res 24:605\u2013612","journal-title":"Anticancer Res"},{"key":"667_CR29","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/35077246","volume":"411","author":"SA Rosenberg","year":"2001","unstructured":"Rosenberg SA (2001) Progress in human tumour immunology and immunotherapy. Nature 411:380\u2013384","journal-title":"Nature"},{"key":"667_CR30","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1097\/00007890-199405150-00016","volume":"57","author":"AF Schaapherder","year":"1994","unstructured":"Schaapherder AF, Daha MR, te Bulte MT, van der Woude FJ, Gooszen HG (1994) Antibody-dependent cell-mediated cytotoxicity against porcine endothelium induced by a majority of human sera. Transplantation 57:1376\u20131382","journal-title":"Transplantation"},{"key":"667_CR31","doi-asserted-by":"crossref","first-page":"9858","DOI":"10.1016\/S0021-9258(17)42779-7","volume":"259","author":"RG Spiro","year":"1984","unstructured":"Spiro RG, Bhoyroo VD (1984) Occurrence of alpha-D-galactosyl residues in the thyroglobulins from several species. Localization in the saccharide chains of the complex carbohydrate units. J Biol Chem 259:9858\u20139866","journal-title":"J Biol Chem"},{"key":"667_CR32","doi-asserted-by":"publisher","first-page":"21437","DOI":"10.1074\/jbc.270.37.21437","volume":"270","author":"AD Thall","year":"1995","unstructured":"Thall AD, Maly P, Lowe JB (1995) Oocyte Gal alpha 1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse. J Biol Chem 270:21437\u201321440","journal-title":"J Biol Chem"},{"key":"667_CR33","first-page":"556","volume":"28","author":"AD Thall","year":"1996","unstructured":"Thall AD, Murphy HS, Lowe JB (1996) alpha 1,3-Galactosyltransferase-deficient mice produce naturally occurring cytotoxic anti-Gal antibodies. Transplant Proc 28:556\u2013557","journal-title":"Transplant Proc"},{"key":"667_CR34","first-page":"987","volume":"63","author":"RC Unfer","year":"2003","unstructured":"Unfer RC, Hellrung D, Link CJ Jr (2003) Immunity to the alpha(1,3)galactosyl epitope provides protection in mice challenged with colon cancer cells expressing alpha(1,3)galactosyl-transferase: a novel suicide gene for cancer gene therapy. Cancer Res 63:987\u2013993","journal-title":"Cancer Res"},{"key":"667_CR35","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1084\/jem.190.3.355","volume":"190","author":"A van Elsas","year":"1999","unstructured":"van Elsas A, Hurwitz AA, Allison JP (1999) Combination immunotherapy of B16 melanoma using anti-cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) and granulocyte\/macrophage colony-stimulating factor (GM-CSF)-producing vaccines induces rejection of subcutaneous and metastatic tumors accompanied by autoimmune depigmentation. J Exp Med 190:355\u2013366","journal-title":"J Exp Med"},{"key":"667_CR36","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1084\/jem.194.4.481","volume":"194","author":"A van Elsas","year":"2001","unstructured":"van Elsas A, Sutmuller RP et al (2001) Elucidating the autoimmune and antitumor effector mechanisms of a treatment based on cytotoxic T lymphocyte antigen-4 blockade in combination with a B16 melanoma vaccine: comparison of prophylaxis and therapy. J Exp Med 194:481\u2013489","journal-title":"J Exp Med"},{"key":"667_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1097\/00007890-199607150-00020","volume":"62","author":"H Watier","year":"1996","unstructured":"Watier H, Guillaumin JM, Piller F, Lacord M, Thibault G, Lebranchu Y, Monsigny M, Bardos P (1996) Removal of terminal alpha-galactosyl residues from xenogeneic porcine endothelial cells. Decrease in complement-mediated cytotoxicity but persistence of IgG1-mediated antibody-dependent cell-mediated cytotoxicity. Transplantation 62:105\u2013113","journal-title":"Transplantation"},{"key":"667_CR38","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0966-3274(96)80050-5","volume":"4","author":"H Watier","year":"1996","unstructured":"Watier H, Guillaumin JM, Vallee I, Thibault G, Gruel Y, Lebranchu Y, Bardos P (1996) Human NK cell-mediated direct and IgG-dependent cytotoxicity against xenogeneic porcine endothelial cells. Transpl Immunol 4:293\u2013299","journal-title":"Transpl Immunol"},{"key":"667_CR39","first-page":"1707","volume":"61","author":"Z Zhu","year":"2001","unstructured":"Zhu Z, Sanchez-Sweatman O, Huang X, Wiltrout R, Khokha R, Zhao Q, Gorelik E (2001) Anoikis and metastatic potential of cloudman S91 melanoma cells. Cancer Res 61:1707\u20131716","journal-title":"Cancer Res"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0667-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-005-0667-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0667-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-005-0667-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,23]],"date-time":"2023-05-23T16:13:47Z","timestamp":1684858427000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-005-0667-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5,12]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2005,10]]}},"alternative-id":["667"],"URL":"https:\/\/doi.org\/10.1007\/s00262-005-0667-4","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,5,12]]},"assertion":[{"value":"31 August 2004","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}